Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest
Phase of Trial: Phase III
Latest Information Update: 15 Apr 2017
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Registrational; Therapeutic Use
- Sponsors LEO Pharma
- 15 Mar 2017 Status changed from active, no longer recruiting to completed.
- 23 May 2016 Status changed from recruiting to active, no longer recruiting.
- 02 Mar 2016 Planned End Date changed from 1 Jan 2017 to 1 Feb 2017 as per ClinicalTrials.gov record.